查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1709463

非侵入性幽门螺旋桿菌检测市场，按检测类型、按技术、按分布、按最终用户、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Non-invasive Helicobacter Pylori Testing Market, By Test Type, By Technology, By Distribution, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 298 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年非侵入性幽门螺旋桿菌检测市场规模价值 2.9733 亿美元，2025 年至 2032 年的复合年增长率为 7.50%。

非侵入性幽门螺旋桿菌检测市场-市场动态

为了方便起见，家庭使用幽门螺旋桿菌检测试剂盒的需求不断增加。

对家用幽门螺旋桿菌检测试剂盒的需求不断增长，这是非侵入性幽门螺旋桿菌检测市场的主要驱动力。消费者喜欢方便的、在家中就能进行的诊断解决方案，无需前往诊所就诊。这些试剂盒具有隐私性、易用性和快速结果等特点，对于早期检测很有吸引力。远距医疗和数位医疗平台的兴起进一步支持了它们的采用，允许根据测试结果进行远端咨询。此外，人们对胃病和预防性医疗保健的认识不断提高也推动了市场的成长。快速抗原和呼气测试技术的进步提高了家庭测试的准确性和可靠性。自我检测解决方案的监管批准正在扩大其可近性，特别是在医疗保健基础设施有限的地区。电子商务的不断普及也促进了销售，使得这些套件广泛普及。随着医疗保健向个人化和预防性医疗转变，家庭幽门螺旋桿菌检测预计将会出现强烈的需求。

非侵入性幽门螺旋桿菌检测市场－关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 7.50%。

根据测试类型细分，预计尿素呼气试验 (UBT) 将在 2024 年占据最大市场份额

根据技术细分，分子诊断是 2024 年的领先技术

根据分销细分，医院药局是 2024 年的主要分销管道

根据最终用户细分，医院和诊所是 2024 年领先的最终用户

按地区划分，亚太地区是 2024 年最大的收入来源

非侵入性幽门螺旋桿菌检测市场-細項分析：

全球非侵入性幽门螺旋桿菌检测市场根据检测类型、技术、分布、最终用户和地区进行细分。

根据测试类型，市场分为三类：尿素呼气测试（UBT）、粪便抗原测试（SAT）、血液抗体测试。尿素呼气试验 (UBT) 因其在检测活动性感染方面的高准确性、易用性和可靠性而在非侵入性幽门螺旋桿菌检测市场占据主导地位。与无法区分过去感染和现在感染的血液抗体测试不同，UBT 可直接测量尿素酶活性，这是幽门螺旋桿菌存在的关键标誌。由于其非侵入性和快速的结果，它在医院、诊断实验室和家庭环境中受到广泛青睐。

医疗保健专业人士青睐 UBT，因为它可以提供即时感染状况，使其成为治疗监测和根除确认的黄金标准。该测试也得到了全球卫生组织的认可，进一步提高了其采用率。技术进步带来了便携式和易于使用的呼吸测试设备，提高了可及性。此外，胃病患病率的上升和政府支持的筛检计画也支持了市场的成长。随着对高效且患者友好的诊断方法的需求不断增加，UBT 仍然是最广泛使用的非侵入性幽门螺旋桿菌测试。

根据技术，市场分为三类：分子诊断、基于免疫测定的测试、色谱技术。分子诊断技术凭藉其高灵敏度、特异性和检测低细菌负荷的能力，在非侵入性幽门螺旋桿菌检测市场中占据主导地位。与传统方法不同，分子诊断，特别是基于聚合酶炼式反应 (PCR) 的测试，可以直接识别幽门螺旋桿菌 DNA，即使在无症状患者中也能确保准确的结果。这使得它成为临床实验室和研究环境的首选。

即时 PCR (qPCR) 和次世代定序 (NGS) 的日益普及进一步提高了诊断的精确度。分子测试可以快速提供结果，减少重复测试的需要并能够及时做出治疗决定。此外，这些技术还可以检测抗生素抗药性，有助于指导有效的治疗策略。政府和医疗保健组织正在推广先进的诊断技术以改善胃病管理，从而推动需求。随着诊断和即时分子检测自动化的不断发展，分子诊断仍然是该市场的领先技术。

非侵入性幽门螺旋桿菌检测市场-地理洞察

由于幽门螺旋桿菌感染率高以及人们对胃肠道疾病的认识不断提高，亚太地区非侵入性幽门螺旋桿菌检测市场正在扩大。中国、印度和日本等国家面临严重的幽门螺旋桿菌相关疾病负担，因此对早期和准确的诊断的需求很大。尿素呼气试验 (UBT) 和粪便抗原测试 (SAT) 由于其可靠性和非侵入性而越来越受到人们的欢迎。政府推动的胃癌筛检计划进一步支持了市场成长。该地区不断扩大的医疗保健基础设施、不断增加的可支配收入以及日益增长的医疗旅游业提高了获得先进诊断方法的可及性。此外，透过电子商务平台提供的家用检测试剂盒越来越多，这也推动了市场渗透。技术进步和创新诊断解决方案的监管批准继续塑造市场格局。

由于中国幽门螺旋桿菌感染率高，影响到近50%的人口，因此中国非侵入性幽门螺旋桿菌检测市场正经历强劲成长。人们对胃病、溃疡和胃癌风险的认识不断提高，推动了对早期和非侵入性诊断方法的需求。中国政府一直在推动胃癌筛检计划，进一步加速市场扩张。

尿素呼气试验（UBT）因其准确度高、方便性等特点，是中国应用最广泛的检测方法。粪便抗原测试（SAT）的采用也正在增长，特别是在医院和诊断实验室。同时，随着电子商务平台和远距医疗服务的兴起，家庭幽门螺旋桿菌检测试剂盒的供应量正在增加。由于方便、实惠且可减少医院就诊次数，消费者更喜欢在家中进行诊断。

非侵入性幽门螺旋桿菌检测市场-竞争格局：

非侵入性幽门螺旋桿菌检测市场竞争激烈，各公司都专注于技术进步、产品创新和策略合作，以扩大市场份额。赛默飞世尔科技、雅培和 DiaSorin 等领先公司在分子诊断、免疫测定试剂盒和尿素呼气测试领域占据主导地位。不断增加的研发投入正在提高测试的准确性，而诊断实验室的自动化正在提高效率。

家庭检测试剂盒和数位医疗解决方案的兴起进一步加剧了竞争。公司也在扩大其全球分销网络，尤其是在新兴市场。监管部门的批准和政府支持的筛选计划继续影响市场动态。

最新动态：

2023 年 7 月，Meridian Bioscience 的最新幽门螺旋桿菌诊断测试 Premier HpSA Flex 获得 FDA 批准，标誌着非侵入性测试取得了重大进展。这项发展巩固了该公司在非侵入性幽门螺旋桿菌检测市场的地位，并增强了其诊断产品。

目录

第一章：非侵入性幽门螺旋桿菌检测市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 非侵入性幽门螺旋桿菌检测市场片段（依检测类型）
    • 非侵入性幽门螺旋桿菌检测市场（按技术）
    • 非侵入性幽门螺旋桿菌检测市场片段（按配销通路）
    • 非侵入性幽门螺旋桿菌检测市场片段（按最终用户）
    • 非侵入性幽门螺旋桿菌检测市场（按国家/地区）
    • 非侵入性幽门螺旋桿菌检测市场（按地区）
  • 竞争洞察

第三章：非侵入性幽门螺旋桿菌检测主要市场趋势

  • 非侵入性幽门螺旋桿菌检测市场驱动因素
    • 市场驱动因素的影响分析
  • 非侵入性幽门螺旋桿菌检测市场限制
    • 市场限制的影响分析
  • 非侵入性幽门螺旋桿菌检测市场机会
  • 非侵入性幽门螺旋桿菌检测市场未来趋势

第四章：非侵入性幽门螺旋桿菌检测产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：非侵入性幽门螺旋桿菌检测市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：非侵入性幽门螺旋桿菌检测市场格局

  • 2024年非侵入性幽门螺旋桿菌检测市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：非侵入性幽门螺旋桿菌检测市场 - 按检测类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 尿素呼气试验（UBT）
    • 粪便抗原检测（SAT）
    • 血液抗体检测

第 8 章：非侵入性幽门螺旋桿菌检测市场 - 依技术

  • 概述
    • 按技术细分的市场份额分析
    • 分子诊断
    • 基于免疫测定的检测
    • 色谱技术

第九章：非侵入性幽门螺旋桿菌检测市场－按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 机器翻译集成
    • 医院药房
    • 零售药局
    • 网路药局

第 10 章：非侵入性幽门螺旋桿菌检测市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院和诊所
    • 诊断实验室
    • 居家照护环境

第 11 章：非侵入性幽门螺旋桿菌检测市场-按地区

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美非侵入性幽门螺旋桿菌检测主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模及预测（按配销通路）
    • 北美市场规模及预测（按最终用户）
    • 美国
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲非侵入性幽门螺旋桿菌检测主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模及预测（按配销通路）
    • 欧洲市场规模及预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区非侵入性幽门螺旋桿菌检测主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依测试类型）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（按配销通路）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲非侵入性幽门螺旋桿菌检测主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按测试类型）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（按配销通路）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲非侵入性幽门螺旋桿菌检测主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依测试类型）
    • MEA 市场规模及预测（依技术）
    • MEA 市场规模及预测（依配销通路）
    • MEA 市场规模及预测（依最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 12 章：主要供应商分析-非侵入性幽门螺旋桿菌检测产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • DiaSorin SpA
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • QuidelOrtho Corporation
    • Meridian Bioscience, Inc.
    • Coris BioConcept
    • Sekisui Diagnostics
    • Alfa Scientific Designs, Inc.
    • Halyard Health, Inc.
    • Kibion AB
    • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
    • CerTest Biotec SL
    • BIOHIT HealthCare Ltd.
    • Medline Industries, LP
    • Cardinal Health, Inc.
    • Luminex Corporation

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4933

REPORT HIGHLIGHT

Non-invasive Helicobacter Pylori Testing Market size was valued at US$ 297.33 Million in 2024, expanding at a CAGR of 7.50% from 2025 to 2032.

The non-invasive Helicobacter pylori (H. pylori) testing market focuses on diagnostic methods that detect infections without requiring endoscopic procedures. These tests include urea breath tests (UBT), stool antigen tests (SAT), and blood antibody tests. UBT is highly accurate, detecting urease enzyme activity, while SAT identifies bacterial antigens in stool samples. Blood tests check for antibodies but are less reliable for active infections. The market is driven by the high prevalence of H. pylori, linked to ulcers and gastric cancer, and the increasing preference for non-invasive diagnostics. Growing awareness, improved healthcare access, and advancements in point-of-care testing further boost demand. North America, Europe, and Asia-Pacific lead the market due to well-established healthcare systems and rising gastrointestinal disease cases. Regulatory approvals and innovations in diagnostic technology continue to shape market expansion.

Non-invasive Helicobacter Pylori Testing Market- Market Dynamics

Rising demand for home-based H. pylori testing kits for convenience.

The growing demand for home-based H. pylori testing kits is a key driver in the non-invasive H. pylori testing market. Consumers prefer convenient, at-home diagnostic solutions that eliminate the need for clinical visits. These kits offer privacy, ease of use, and quick results, making them attractive for early detection. The rise of telemedicine and digital healthcare platforms further supports their adoption, allowing remote consultations based on test results. Additionally, increasing awareness about gastric diseases and preventive healthcare fuels market growth. Advancements in rapid antigen and breath test technologies enhance the accuracy and reliability of at-home testing. Regulatory approvals for self-testing solutions are expanding accessibility, especially in regions with limited healthcare infrastructure. Growing e-commerce penetration also boosts sales, making these kits widely available. As healthcare shifts toward personalized and preventive medicine, home-based H. pylori tests are expected to see strong demand.

Non-invasive Helicobacter Pylori Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.50% over the forecast period (2025-2032)

Based on Test Type segmentation, Urea Breath Test (UBT) was predicted to show maximum market share in the year 2024

Based on Technology segmentation, Molecular Diagnostics was the leading Technology in 2024

Based on distribution segmentation, Hospital-Based Pharmacies was the leading distribution in 2024

Based on End-user segmentation, Hospitals & Clinics was the leading End-user in 2024

On the basis of region, Asia-Pacific was the leading revenue generator in 2024

Non-invasive Helicobacter Pylori Testing Market- Segmentation Analysis:

The Global Non-invasive Helicobacter Pylori Testing Market is segmented on the basis of Test Type, Technology, Distribution, end-user, and Region.

The market is divided into three categories based on Test Type: Urea Breath Test (UBT), Stool Antigen Test (SAT), Blood Antibody Test. The Urea Breath Test (UBT) dominates the non-invasive H. pylori testing market due to its high accuracy, ease of use, and reliability in detecting active infections. Unlike blood antibody tests, which cannot distinguish between past and present infections, UBT directly measures urease enzyme activity, a key marker of H. pylori presence. It is widely preferred in hospitals, diagnostic labs, and home-based settings due to its non-invasive nature and quick results.

Healthcare professionals favor UBT because it provides real-time infection status, making it the gold standard for treatment monitoring and eradication confirmation. The test is also endorsed by global health organizations, further increasing adoption. Technological advancements have led to portable and easy-to-use breath test devices, enhancing accessibility. Additionally, the rising prevalence of gastric diseases and government-backed screening programs support market growth. With increasing demand for efficient and patient-friendly diagnostics, UBT remains the most widely used non-invasive H. pylori test.

The market is divided into three categories based on Technology: Molecular Diagnostics, Immunoassay-Based Testing, Chromatographic Techniques. Molecular Diagnostics dominates the non-invasive H. pylori testing market due to its high sensitivity, specificity, and ability to detect low bacterial loads. Unlike traditional methods, molecular diagnostics, particularly Polymerase Chain Reaction (PCR)-based tests, identify H. pylori DNA directly, ensuring accurate results even in asymptomatic patients. This makes it a preferred choice in clinical laboratories and research settings.

The increasing adoption of real-time PCR (qPCR) and next-generation sequencing (NGS) has further improved diagnostic precision. Molecular tests provide rapid results, reducing the need for repeated testing and enabling timely treatment decisions. Moreover, these technologies allow for antibiotic resistance detection, helping guide effective treatment strategies. Governments and healthcare organizations are promoting advanced diagnostic techniques to improve gastric disease management, driving demand. As automation in diagnostics and point-of-care molecular tests continue to advance, molecular diagnostics remains the leading technology in this market.

Non-invasive Helicobacter Pylori Testing Market- Geographical Insights

The Asia-Pacific non-invasive H. pylori testing market is expanding due to the high prevalence of H. pylori infections and increasing awareness of gastrointestinal diseases. Countries like China, India, and Japan have a significant burden of H. pylori-related conditions, driving the demand for early and accurate diagnostics. The adoption of urea breath tests (UBT) and stool antigen tests (SAT) is rising due to their reliability and non-invasive nature. Government initiatives promoting gastric cancer screening programs further support market growth. The expanding healthcare infrastructure, rising disposable income, and growing medical tourism in the region enhance accessibility to advanced diagnostics. Additionally, the increasing availability of home-based testing kits through e-commerce platforms is fueling market penetration. Technological advancements and regulatory approvals for innovative diagnostic solutions continue to shape the market landscape.

The non-invasive H. pylori testing market in China is witnessing strong growth due to the high prevalence of H. pylori infections, affecting nearly 50% of the population. The increasing awareness about gastric diseases, ulcers, and gastric cancer risks is driving the demand for early and non-invasive diagnostic methods. The Chinese government has been promoting gastric cancer screening programs, further accelerating market expansion.

Urea breath tests (UBT) are the most widely used method in China due to their high accuracy and convenience. The adoption of stool antigen tests (SAT) is also growing, particularly in hospitals and diagnostic laboratories. Meanwhile, the availability of home-based H. pylori testing kits is increasing, driven by the rise of e-commerce platforms and telemedicine services. Consumers prefer at-home diagnostics due to convenience, affordability, and reduced hospital visits.

Non-invasive Helicobacter Pylori Testing Market- Competitive Landscape:

The non-invasive H. pylori testing market is highly competitive, with companies focusing on technological advancements, product innovation, and strategic collaborations to expand their market share. Leading players such as Thermo Fisher Scientific, Abbott, and DiaSorin dominate with molecular diagnostics, immunoassay-based kits, and urea breath tests. Increasing R&D investments are enhancing test accuracy, while automation in diagnostic labs is improving efficiency.

The rise of home-based testing kits and digital healthcare solutions is further intensifying competition. Companies are also expanding their global distribution networks, especially in emerging markets. Regulatory approvals and government-backed screening programs continue to influence market dynamics.

Recent Developments:

In July 2023, Meridian Bioscience secured FDA clearance for its latest H. pylori diagnostic test, Premier HpSA Flex, marking a significant advancement in non-invasive testing. This development strengthened the company's position in the non-invasive H. pylori testing market and enhanced its diagnostic offerings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • DiaSorin S.p.A.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • QuidelOrtho Corporation
  • Meridian Bioscience, Inc.
  • Coris BioConcept
  • Sekisui Diagnostics
  • Alfa Scientific Designs, Inc.
  • Halyard Health, Inc.
  • Kibion AB
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
  • CerTest Biotec S.L.
  • BIOHIT HealthCare Ltd.
  • Medline Industries, LP
  • Cardinal Health, Inc.
  • Luminex Corporation

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Urea Breath Test (UBT)
  • Stool Antigen Test (SAT)
  • Blood Antibody Test

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassay-Based Testing
  • Chromatographic Techniques

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY DISTRIBUTION- CHANNEL MARKET ANALYSIS, 2019 - 2032

  • Machine Translation Integration
  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care Settings

GLOBAL NON-INVASIVE HELICOBACTER PYLORI TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Non-invasive Helicobacter Pylori Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Non-invasive Helicobacter Pylori Testing Market Snippet by Test Type
    • 2.1.2. Non-invasive Helicobacter Pylori Testing Market Snippet by Technology
    • 2.1.3. Non-invasive Helicobacter Pylori Testing Market Snippet by Distribution Channel
    • 2.1.4. Non-invasive Helicobacter Pylori Testing Market Snippet by End-user
    • 2.1.5. Non-invasive Helicobacter Pylori Testing Market Snippet by Country
    • 2.1.6. Non-invasive Helicobacter Pylori Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Non-invasive Helicobacter Pylori Testing Key Market Trends

  • 3.1. Non-invasive Helicobacter Pylori Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Non-invasive Helicobacter Pylori Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Non-invasive Helicobacter Pylori Testing Market Opportunities
  • 3.4. Non-invasive Helicobacter Pylori Testing Market Future Trends

4. Non-invasive Helicobacter Pylori Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Non-invasive Helicobacter Pylori Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Non-invasive Helicobacter Pylori Testing Market Landscape

  • 6.1. Non-invasive Helicobacter Pylori Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Non-invasive Helicobacter Pylori Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Urea Breath Test (UBT)
    • 7.1.3. Stool Antigen Test (SAT)
    • 7.1.4. Blood Antibody Test

8. Non-invasive Helicobacter Pylori Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Molecular Diagnostics
    • 8.1.3. Immunoassay-Based Testing
    • 8.1.4. Chromatographic Techniques

9. Non-invasive Helicobacter Pylori Testing Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Machine Translation Integration
    • 9.1.3. Hospital-Based Pharmacies
    • 9.1.4. Retail Pharmacies
    • 9.1.5. Online Pharmacies

10. Non-invasive Helicobacter Pylori Testing Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Home Care Settings

11. Non-invasive Helicobacter Pylori Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.8. The U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Non-invasive Helicobacter Pylori Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Non-invasive Helicobacter Pylori Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. DiaSorin S.p.A.
    • 12.2.3. Abbott Laboratories
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. QuidelOrtho Corporation
    • 12.2.6. Meridian Bioscience, Inc.
    • 12.2.7. Coris BioConcept
    • 12.2.8. Sekisui Diagnostics
    • 12.2.9. Alfa Scientific Designs, Inc.
    • 12.2.10. Halyard Health, Inc.
    • 12.2.11. Kibion AB
    • 12.2.12. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
    • 12.2.13. CerTest Biotec S.L.
    • 12.2.14. BIOHIT HealthCare Ltd.
    • 12.2.15. Medline Industries, LP
    • 12.2.16. Cardinal Health, Inc.
    • 12.2.17. Luminex Corporation

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us